ambevsacvm358jan17_6k1.htm - Generated by SEC Publisher for SEC Filing

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of February, 2017

Commission File Number 1565025

AMBEV S.A.

(Exact name of registrant as specified in its charter)

AMBEV S.A.

(Translation of Registrant's name into English)

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___ Form 40-F _______

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes _______ No ___X____

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

In January 2017:

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002.⁽¹⁾

( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

Company Name: Ambev S.A.
Name: Ambev S.A.							CPF/CNPJ: 07.526.557/0001-00
Qualification: Outstanding Shares in Treasury
Initial Balance
Securities / Derivatives	Securities Characteristics (2)				Quantity			%
								Same Class and Type			Total
Shares	Common				16,512,491			0.1051			0.1051
Transactions in the month
Securities / Derivatives	Securities Characteristics (2)	Intermediary	Operation	Day		Quantity			Price	Volume (R$) (3)
Shares	Common	Direct with the Company	Conversion in ADRs	04		21,672			0.00000	0.00
Shares	Common	Direct with the Company	Conversion in ADRs	18		23,377			0.00000	0.00
Shares	Common	Direct with the Company	Conversion in ADRs	24		65,874			0.00000	0.00
Shares	Common	Direct with the Company	Conversion in ADRs	27		283,143			0.00000	0.00
			Total Conversion ADRs (Out)			394,066				0.00

Shares	Common	Direct with the Company	Exerc Options	03		35,525			1.322840	46,993.89
Shares	Common	Direct with the Company	Exerc Options	03		38,650			3.350960	129,514.60
Shares	Common	Direct with the Company	Exerc Options	03		30,125			9.359600	281,957.95
Shares	Common	Direct with the Company	Exerc Options	03		25,385			11.972000	303,909.22
Shares	Common	Direct with the Company	Exerc Options	11		44,675			0.015000	670.13
Shares	Common	Direct with the Company	Exerc Options	13		95,210			11.972000	1,139,854.12
Shares	Common	Direct with the Company	Exerc Options	15		44,675			0.015000	670.13
Shares	Common	Direct with the Company	Exerc Options	16		169,175			4.540000	768,054.50
Shares	Common	Direct with the Company	Exerc Options	16		25,385			11.972000	303,909.22
Shares	Common	Direct with the Company	Exerc Options	17		30,125			9.359600	281,957.95
Shares	Common	Direct with the Company	Exerc Options	20		84,950			5.367600	455,977.62
Shares	Common	Direct with the Company	Exerc Options	20		68,625			5.359600	367,802.55
Shares	Common	Direct with the Company	Exerc Options	20		37,000			6.958800	257,475.60
Shares	Common	Direct with the Company	Exerc Options	20		57,225			9.359600	535,603.11
Shares	Common	Direct with the Company	Exerc Options	20		183,585			11.710000	2,149,780.35
Shares	Common	Direct with the Company	Exerc Options	20		159,940			11.972000	1,914,801.68
Shares	Common	Direct with the Company	Exerc Options	23		30,125			9.359600	281,957.95
Shares	Common	Direct with the Company	Exerc Options	23		25,385			11.972000	303,909.22
Shares	Common	Direct with the Company	Exerc Options	24		84,475			0.061064	5,158.38
Shares	Common	Direct with the Company	Exerc Options	24		30,125			9.359600	281,957.95
Shares	Common	Direct with the Company	Exerc Options	24		48,235			11.972000	577,469.42
			Total Sell			1,348,600				10,389,385.54

Shares	Common	Direct with the Company	Plan of Shares Acquisition	03		2,828,416			16.64	47,064,842.24
Shares	Common	Direct with the Company	Plan of Shares Acquisition	13		67,328			16.93	1,139,863.04
Shares	Common	Direct with the Company	Plan of Shares Acquisition	16		68,444			17.05	1,166,970,20
Shares	Common	Direct with the Company	Plan of Shares Acquisition	17		16,393			17.20	281,959.60
Shares	Common	Direct with the Company	Plan of Shares Acquisition	20		346,800			17.35	6,016,980.00
Shares	Common	Direct with the Company	Plan of Shares Acquisition	23		33,788			17.34	585,883.92
Shares	Common	Direct with the Company	Plan of Shares Acquisition	24		63,505			17.30	1,098,636.50
Shares	Common	Direct with the Company	Plan of Shares Acquisition	26		19,673			17.31	340,539.63
Shares	Common	Direct with the Company	Plan of Shares Acquisition	31		34,884			17.20	600,004.80
			Total Buy			3,479,231				58,295,679.93
Final Balance
Securities / Derivatives	Securities Characteristics (2)				Quantity			%
								Same Class and Type			Total
Shares	Common				18,249,056			0.1161			0.1161

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price.

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

In December 2016:

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002.⁽¹⁾

( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

Company Name: Ambev S.A.
Name: Ambev S.A.							CPF/CNPJ: 07.526.557/0001-00
Qualification: Outstanding Shares in Treasury
Initial Balance
Securities / Derivatives	Securities Characteristics (2)				Quantity			%
								Same Class and Type			Total
ADR (*)	Common				0			0.0000			0.0000
Transactions in the month
Securities / Derivatives	Securities Characteristics (2)	Intermediary	Operation	Day		Quantity			Price USD	Volume (USD) (3)
ADR (*)	Common	Direct with the Company	Conversion in ADRs	04		21,672			0.00000	0.00
ADR (*)	Common	Direct with the Company	Conversion in ADRs	18		23,377			0.00000	0.00
ADR (*)	Common	Direct with the Company	Conversion in ADRs	24		65,874			0.00000	0.00
ADR (*)	Common	Direct with the Company	Conversion in ADRs	27		283,143			0.00000	0.00
			Total Conversion ADRs (In)			394,066				0.00

ADR (*)	Common	Direct with the Company	Plan of Shares Acquisition	04		17,803			5.11	90,974.24
ADR (*)	Common	Direct with the Company	Plan of Shares Acquisition	18		15,023			5.34	80,225.28
ADR (*)	Common	Direct with the Company	Plan of Shares Acquisition	24		120,676			5.43	655,273.42
ADR (*)	Common	Direct with the Company	Plan of Shares Acquisition	27		57,957			5.45	315,860.94
			Total Buy			211,459				1,142,333.88

ADR (*)	Common	Direct with the Company	Exerc Options	04		39,475			2.3046038	90,974.24
ADR (*)	Common	Direct with the Company	Exerc Options	18		38,400			2.0892000	80,225.28
ADR (*)	Common	Direct with the Company	Exerc Options	24		103,850			2.0892000	216,963.42
ADR (*)	Common	Direct with the Company	Exerc Options	24		82,700			5.3000000	438,310.00
ADR (*)	Common	Direct with the Company	Exerc Options	27		189,550			0.0000000	0.00
ADR (*)	Common	Direct with the Company	Exerc Options	27		42,675			1.1784400	50,290.10
ADR (*)	Common	Direct with the Company	Exerc Options	27		25,250			2.2824580	57,632.06
ADR (*)	Common	Direct with the Company	Exerc Options	27		52,325			1.6760000	87,696.70
ADR (*)	Common	Direct with the Company	Exerc Options	27		31,300			3.8416000	120,242.08
			Total Sell			605,525				1,142,333.88
Final Balance
Securities / Derivatives	Securities Characteristics (2)				Quantity			%
								Same Class and Type			Total
ADR (*)	Common				0			0.0000			0.0000

1. When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

2. Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

3. Quantity multiplied by price.

(*) Each ADR is equivalent to 1 (one) share.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: February 10, 2017


	AMBEV S.A.

	By:	/s/ Ricardo Rittes de Oliveira Silva
		Ricardo Rittes de Oliveira Silva Chief Financial and Investor Relations Officer

Initial Balance

Transactions in the month

Final Balance

Initial Balance

Transactions in the month

Final Balance